Northeast Iowa IA

Pfizer Receives European Approval for ZIRABEV (bevacizumab), a Biosimilar to Avastin*

Oelwein Daily Register

Feb 19, 2019

NEW YORK--(BUSINESS WIRE)--Feb 19, 2019--Pfizer Inc. (NYSE: PFE) today announced the European Commission (EC) has approved ZIRABEV for the treatment of metastatic carcinoma of the…

Read the full story at Oelwein Daily Register

Pfizer Receives European Approval for ZIRABEV (bevacizumab), a Biosimilar to Avastin*

More from Northeast Iowa

Hammerand and No. 1 Men's Cross Country Place First at Interregional Invite; Maas' PR Leads No. 24 Women's Cross Country to Eighth-Place Finish

Knights Fall To Storm in Straight-Sets

Wartburg Rallies Past Central in Five Sets

What to know about Tavis Hall being hired at Waterloo Schools'

FRIDAY FLASHBACK: Penguins down Panthers in top 25 battle

Jurors hear of search for gun in Waterloo shift change homicide

Iowa State selects Jared Benko as next athletic director

Minnesota man charged in 1995 cold case murder of Angela Buck